We serve Chemical Name:Methyl 1-hydroxycyclopropanecarboxylate CAS:33689-29-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Methyl 1-hydroxycyclopropanecarboxylate
CAS.NO:33689-29-1
Synonyms:1-Hydroxy-cyclopropancarbonsaeure-methylester;Cyclopropanecarboxylic acid, 1-hydroxy-, methyl ester;methyl 1-hydroxylcyclopropanecarboxylate;METHYL 1-HYDROXY-1-CYCLOPROPANECARBOXYLATE;Hydroxy-cyclopropanecarboxylic acid methyl ester;Methyl 1-hydroxy-1-cyclopropane carboxylate;1-Hydroxycyclopropanecarboxylic Acid Methyl Ester;Methyl 1-hydroxycyclopropanecarboxylate
Molecular Formula:C5H8O3
Molecular Weight:116.115
HS Code:2918199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:134.6±13.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.521
PSA:46.53000
Exact Mass:116.047340
LogP:-1.05
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:3277
Packing Group:
Contact us for information like 1-Hydroxy-cyclopropancarbonsaeure-methylester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 1-hydroxycyclopropanecarboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Hydroxy-cyclopropanecarboxylic acid methyl ester Use and application,Methyl 1-hydroxycyclopropanecarboxylate technical grade,usp/ep/jp grade.
Related News: Like SARS, this latest outbreak is caused by a coronavirus, a family of viruses common to animals that range from the common cold, to more serious diseases, like Middle East respiratory syndrome (MERS). Methyl 1-hydroxycyclopropanecarboxylate manufacturer A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018. Methyl 1-hydroxycyclopropanecarboxylate supplier After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. Methyl 1-hydroxycyclopropanecarboxylate vendor A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018. Methyl 1-hydroxycyclopropanecarboxylate factory Like SARS, this latest outbreak is caused by a coronavirus, a family of viruses common to animals that range from the common cold, to more serious diseases, like Middle East respiratory syndrome (MERS).
